Texas Instruments director Curtis C. Farmer received a grant of stock units as part of his director compensation. On March 20, 2026, he was awarded 146.0500 stock units that convert into common stock on a one-for-one basis at no exercise price.
These stock units were credited under the Texas Instruments 2018 Director Compensation Plan and will be settled in common stock after he leaves the board. End-of-period holdings show 2,049.1100 stock units and 2,911.0000 shares of common stock held directly.
Texas Instruments director Pamela H. Patsley received a grant of 146.050 stock units on common stock on March 20, 2026. These stock units were credited at a reference price of $188.29 per unit and convert into common stock on a one-for-one basis.
The stock units were granted under the Texas Instruments 2018 Director Compensation Plan and will be settled in common stock after she terminates service as a director. Following this grant, end-of-period holdings total 64,778.700 stock units and 34,487 shares of common stock held directly.
Texas Instruments Incorporated is asking shareholders to vote at its April 16, 2026 annual meeting on five key items: electing 12 directors, approving executive pay on an advisory basis, ratifying Ernst & Young LLP as auditor for 2026, a stockholder proposal on written consent, and any other proper business.
The board is largely independent, with 11 of 12 directors meeting its independence standards, and has combined the chair and CEO roles under Haviv Ilan, supported by a lead independent director. Non-employee directors receive cash retainers plus annual stock options and restricted stock units, aligning their interests with shareholders.
Executive pay is strongly performance-based, mixing salary, annual bonus, profit sharing, and equity awards. For 2025, TI reported 13.0% revenue growth and a 34.1% operating margin, leading the compensation committee to raise named executive officer bonuses by 10%, while keeping equity grants generally targeted around market medians.
Texas Instruments senior vice president Hagop H. Kozanian sold 6,843 shares of common stock in an open-market transaction. The sale occurred on February 17, 2026 at a weighted average price of $225.9488 per share, with prices ranging from $225.62 to $226.13.
After this transaction, Kozanian directly owned 75,425 shares of Texas Instruments common stock.
Texas Instruments Sr. Vice President Ahmad Bahai reported exercising a stock option for 6,500 shares of common stock at $79.26 per share on February 11, 2026, then selling 6,500 shares in the open market at a weighted average price of $230.7872 per share. Following these transactions, he directly owned 42,488 shares of common stock and 3,660 nonqualified stock options.
Texas Instruments senior vice president Gary Mark reported option exercises and share sales. On February 11, 2026, he exercised 12,921 nonqualified stock options at $110.15 per share, receiving the same number of common shares. He then sold 12,921 shares that day at a weighted average price of $230.0988 per share in open-market transactions, and sold 10,248 shares on February 10, 2026 at a weighted average price of $220.8331 per share. After these transactions, he directly owned 45,547 Texas Instruments common shares.
Texas Instruments Sr. Vice President & CFO Rafael R. Lizardi reported an option exercise and multiple share sales. On February 10, 2026, he exercised a nonqualified stock option for 64,532 shares of common stock at an exercise price of $130.52 per share, increasing his directly held common stock to 157,082 shares.
That same day, he sold 44,055 shares at a weighted average price of $220.5105 and 20,477 shares at a weighted average price of $221.2213. On February 11, 2026, he sold an additional 7,096 shares at a weighted average price of $230.7795. After these transactions, he directly owns 85,454 shares of common stock and indirectly owns 33,994 shares through an entity labeled SLAT.
Texas Instruments insider plans to sell additional shares under Rule 144. A holder intends to sell 7,096 shares of common stock through UBS Financial Services on NASDAQ, with an aggregate market value of $1,637,611. The filing notes 907,550,774 common shares outstanding and an approximate sale date of February 11, 2026.
The 7,096 shares were acquired on January 30, 2026 via restricted stock units from Texas Instruments and are shown as paid in cash on February 11, 2026. Over the prior three months, Rafael Lizardi sold 64,532 common shares on February 10, 2026 for gross proceeds of $14,244,537.
A shareholder of Texas Instruments plans to sell 64,532 common shares under Rule 144. The shares are to be sold through UBS Financial Services Inc. on the NASDAQ, with an aggregate market value of $14,244,537 and an approximate sale date of February 10, 2026.
The seller acquired these common shares on January 24, 2020 through an ESOP transaction from Texas Instruments and paid for them in cash. This notice also confirms the seller represents they are not aware of undisclosed material adverse information about the company’s current or prospective operations.